Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Raj Parekh
Age : 59
Public asset : 41,311 USD
Country of residence : Unknown
Linked companies : Galapagos NV - Eloxx Pharmaceuticals, Inc.

Biography of Raj Parekh 
Dr. Raj B. Parekh is an Independent Director at Eloxx Pharmaceuticals, Inc., a General Partner at Advent Life Sciences LLP, a Chairman at Galapagos NV and a Professor at University of Oxford. He is on the Board of Directors at Eloxx Pharmaceuticals, Inc., Arrakis Therapeutics, Inc., Capella Bioscience Ltd., Advent LS Services Ltd., Aleta Biotherapeutics, Inc., Aleta, Inc., Alpha Anomeric SA, Alpha Anomeric SAS, Amphista Therapeutics Ltd., Arrakis, Inc., Artax, Inc., Aura Biosciences, Inc., Aura, Inc., Cellnovo Ltd., Itara Ltd., Levicept Ltd., Performance Electronics Ltd., Project Paradise Ltd., Rappta Therapeutics Oy, Tridek-One Therapeutics SAS, Zikani Therapeutics, Inc., Novartis Venture Fund and Biocartis SA. Dr. Parekh was previously employed as a General Partner by Advent Venture Partners LLP, a Non-Executive Chairman by Chroma Therapeutics Ltd., a CEO, Chief Scientific Officer & Senior VP-Research by Oxford GlycoSciences Plc, a Director-Supervisory Board by 4-Antibody AG, a Non-Executive Director by Biocartis Group NV, a Chief Executive Officer & Director by Biocartis SA, a Chairman by CoCo Therapeutics Ltd., a Non-Executive Director by EUSA Pharma, Inc., a Non-Executive Director by F2G Ltd., and a Non-Executive Director by Jazz Pharmaceuticals UK Ltd. He also served on the board at Cellnovo Group SA, AVANT Immunotherapeutics, Inc., Celldex Therapeutics, Inc., Celldex Research Corp., Amsterdam Molecular Therapeutics (AMT) Holding NV, Artax Biopharma, Inc., Avant! Corp. (California), Avila Therapeutics, Inc., Biocartis NV, Luxfold S.A., NeRRe Therapeutics Ltd. and Thiakis Ltd. He received his undergraduate degree from the University of Oxford, a graduate degree from the University of Oxford and a doctorate degree from the University of Oxford.


Current positions of Raj Parekh 
Holdings of Raj Parekh 
Raj Parekh : Personal Network 
Most Read News 
06/14ELON MUSK : Bitcoin tops $40,000 after Musk says Tesla could use it again
RE
06/07JEFF BEZOS : Amazon's billionaire founder Jeff Bezos to fly to space next month
RE
06/04JACK DORSEY : Square considering making bitcoin hardware wallet -Dorsey
RE
06/12JEFF BEZOS : Bid of $28 million wins a rocket trip to space with Bezos
RE
06/08CHAMATH PALIHAPITIYA : Palihapitiya's $16 million bet on Clover worth $682 million on Reddit rally
RE
06/04WILLIAM ACKMAN : Ackman reinvents SPAC in Universal Music deal talks
RE
06/11ELON MUSK : 'This car crushes' Musk says, as Tesla launches faster Model S 'Plaid'
RE
06/15JACK MA : Alibaba executive says founder Jack Ma 'lying low' - CNBC
RE
06/10MARIA MARTINEZ : French Industrial Production Unexpectedly Declined in April
DJ
06/06ELON MUSK : Musk says Tesla cancels the longest-range Model S Plaid+
RE
More news


© 2021 People and Ownership :   
Raj Parekh : Connections 


Latest news about Raj Parekh 
04/01Eloxx Pharmaceuticals, Inc. acquired Zikani Therapeutics, Inc. for $25.2 million.
CI
2020Galapagos NV Approves the Appointment of Elisabeth Svanberg and Raj Parekh as Director
CI
More news